Effectofrosiglitazoneonserum IGF-I concentrations in uncontrolled acromegalic patients under conventional medical therapy: Results froma pilot phase 2 study - Bogazzi, F.; Rossi, G.; Lombardi, M.; Raggi, F.; Urbani, C.; Sardella, C.; Cosci, C.; Martino, E. (Journal of endocrinological investigation, 2011)
Keywords: Endocrinology; Medicine; Medicine & Public Health; Metabolic Diseases; Original Articles; Acromegaly; GH; rosiglitazone; IGF-I